Syros Pharmaceuticals announced the appointment of Joseph J. Ferra as the company’s Chief Financial Officer. Mr. Ferra brings significant financial, strategic and leadership experience in the biotechnology industry. Mr. Ferra most recently served as Managing Director and Co-Head of Healthcare Investment Banking at JMP Securities. Prior to JMP, he was a member of the investment banking groups at UBS and JP Morgan. He joins Syros with over 13 years of investment banking experience, including advising on more than $20 billion in equity, debt and M&A transactions for leading biopharmaceutical companies. Earlier in his career, Mr. Ferra served in sales and engineering roles in the life science tools industry.